About Mulpleta
Mulpleta is a NEW orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist. It is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.1
Mulpleta helps increase endogenous platelet production1
Mulpleta upregulates the production of platelets through its agonistic effect on human TPO receptors.
Activation of the TPO receptor by Mulpleta2
